Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E2LR
|
||||
Former ID |
DNC005254
|
||||
Drug Name |
3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-1H-indazole
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527249] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H25N3
|
||||
Canonical SMILES |
C1CN(CCC1CCC2=C3C=CC=CC3=NN2)CC4=CC=CC=C4
|
||||
InChI |
1S/C21H25N3/c1-2-6-18(7-3-1)16-24-14-12-17(13-15-24)10-11-21-19-8-4-5-9-20(19)22-23-21/h1-9,17H,10-16H2,(H,22,23)
|
||||
InChIKey |
NPZKLBFCTYVTBS-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [527249] | |
KEGG Pathway | Glycerophospholipid metabolism | ||||
Cholinergic synapse | |||||
Pathway Interaction Database | ATF-2 transcription factor network | ||||
PathWhiz Pathway | Phospholipid Biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.